ATI RN
Cardiovascular System Practice Exam
1. What is a condition where the heart's ability to pump blood is reduced because the heart muscle is enlarged, thickened, or stiffened?
- A. Cardiomyopathy
- B. Endocarditis
- C. Myocarditis
- D. Aortic stenosis
Correct answer: A
Rationale: Cardiomyopathy is the correct answer. It is a condition characterized by the enlargement, thickening, or stiffening of the heart muscle, leading to a reduced ability of the heart to pump blood effectively. Endocarditis (Choice B) is the inflammation of the inner lining of the heart chambers and valves, not specifically related to the heart muscle. Myocarditis (Choice C) is inflammation of the heart muscle typically caused by a viral infection, not directly related to the heart muscle's structure. Aortic stenosis (Choice D) is a condition characterized by the narrowing of the aortic valve opening, affecting blood flow from the heart's left ventricle to the aorta, different from the structural changes seen in cardiomyopathy.
2. The client is on a beta blocker for hypertension. What should the nurse monitor for?
- A. Bradycardia
- B. Tachycardia
- C. Hypertension
- D. Respiratory distress
Correct answer: A
Rationale: Corrected Rationale: When a client is on a beta blocker for hypertension, the nurse should monitor for bradycardia. Beta blockers are known to decrease heart rate, which can lead to bradycardia. Tachycardia (choice B) is unlikely as beta blockers have the opposite effect. Hypertension (choice C) is the condition being treated, not a side effect of beta blockers. Respiratory distress (choice D) is not a common effect of beta blockers and is not typically monitored in clients taking beta blockers.
3. The healthcare provider is monitoring a client receiving lidocaine IV. What side effect is the healthcare provider most concerned about?
- A. Severe headache
- B. Nausea and vomiting
- C. Seizures
- D. Tremors
Correct answer: C
Rationale: Seizures are the most concerning side effect of lidocaine IV administration due to its potential to indicate lidocaine toxicity, which can lead to serious complications such as cardiovascular collapse. Headache, nausea, and tremors are not typically associated with lidocaine IV and are less concerning compared to seizures in this context.
4. Which neurotransmitter is released by the sympathetic nervous system (SNS) to increase heart rate and the force of contraction of the heart?
- A. Norepinephrine
- B. Epinephrine
- C. Dopamine
- D. Acetylcholine
Correct answer: A
Rationale: The correct answer is Norepinephrine. Norepinephrine is the neurotransmitter released by the sympathetic nervous system that increases heart rate and the force of contraction. Epinephrine, though similar, is more involved in the fight-or-flight response and has a broader range of effects on various organs. Dopamine is not primarily responsible for increasing heart rate and contractility. Acetylcholine is a neurotransmitter that predominantly acts on the parasympathetic nervous system to decrease heart rate and contractility.
5. The healthcare provider is administering IV nitroglycerin to a patient for chest pain. What is the most critical parameter to monitor?
- A. Heart rate
- B. Blood pressure
- C. Oxygen saturation
- D. Respiratory rate
Correct answer: B
Rationale: The correct answer is 'Blood pressure.' Nitroglycerin is a vasodilator that can cause a rapid drop in blood pressure, leading to hypotension. Monitoring the blood pressure is crucial to prevent potential complications such as hypotension-induced dizziness, syncope, or organ hypoperfusion. While heart rate, oxygen saturation, and respiratory rate are important parameters to monitor in a clinical setting, the immediate concern with IV nitroglycerin administration is the risk of hypotension, making blood pressure the most critical parameter to assess.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access